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ABSTRACT
Background: Human Ca2+-activated Cl ion channel 1 (hCLCA1) is expressed in goblet cell hyperplasia in the
airway of asthmatics, and murine CLCA3 is associated with antigen-sensitized and IL-13-induced goblet cell
metaplasia in mice. However, the role of CLCA in goblet cell degranulation is not fully investigated. Niflumic
acid (NFA), a relatively specific CLCA inhibitor, inhibits goblet cell metaplasia, but the effect of NFA on goblet
cell degranulation has not been determined in an asthma model.
Methods: Guinea pigs were sensitized with ovalbumin (OA) twice and then challenged with saline, OA, hista-
mine, and one of the Ca2+-dependent secretagogues, UTP. The PASAB-stained mucus area in the tracheal
epithelium was measured with a computer image analysis system, and the morphology of mucus granules was
examined by transmission electron microscopy. In the in vitro experiment, goblet cells cultured with IL-13 at the
air-liquid interface were stimulated with UTP in the presence or absence of NFA, and the MUC5AC level in cell
lysates was measured by ELISA.
Results: The mucus areas were smaller in the OA-, histamine-, and UTP-challenged animals than in the
saline-challenged animals. NFA inhibited the decrease in mucus area and morphological changes in mucus
granules. UTP caused swelling and exocytosis of mucus granules and MUC5AC secretion by cultured goblet
cells, and NFA inhibited these changes.
Conclusions: NFA inhibited the secretory response of mucus granules in an asthma model, suggesting that
CLCA may be associated with goblet cell degranulation and that CLCA inhibitors may be useful for the treat-
ment of hypersecretion in asthma.
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INTRODUCTION
Goblet cell hyperplasia is one of the central features
of asthma. Mucus hypersecretion due to goblet cell
hyperplasia causes airway narrowing, loss of lung
function, and, occasionally, asthmatic death.1 How-
ever, the specific treatments for mucus hypersecre-
tion are not currently available.
There is increasing evidence of a relationship be-
tween a calcium activated chloride channel and mu-
cus production. hCLCA1 is expressed in goblet cell
hyperplasia in the airway of asthmatics.2 Nakanishi A
et al. reported finding that mCLCA3 (the mouse
counterpart of hCLCA1, alias gob-5) is associated
with goblet cell metaplasia in a murine model of
asthma.3 Long AJ reported observing decreased gob-
let cell metaplasia in ovalbumin-challenged gob-5-
knockout mice.4 Th2 cytokines, especially IL-13, are
central mediators of asthma,5 and IL-13 potently in-
duces both hCLCA1 expression and goblet cell meta-
plasia by human airway epithelial cells.6 Niflumic acid
(NFA) is a relatively specific CLCA inhibitor and has
been shown to inhibit IL-13-induced goblet cell meta-
plasia in a murine model,7 in which mCLCA3 had
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Fig.　1　Effect of nifl umic acid (NFA) on goblet cell degranulation induced by OA chal-
lenge. A) Photomicrographs of tracheal epithelium (PAS/alcian blue stain). a) Saline chal-
lenge, b) OA challenge, c) NFA-pretreated, OA challenge. Scale bar = 20 μm. B) Compari-
son of the PAS/alcian-blue-positive mucus area as a percentage of the total area of the 
tracheal epithelium measured with computer image analysis software. n = 4-6. **p < 0.01, 
OA challenge or indomethacin (INDO)-pretreated, OA challenge vs. saline challenge or 
NFA-pretreated, OA challenge.
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been specifically induced by IL-13. These findings
suggest that CLCA expression may be strongly asso-
ciated with antigen-sensitized- or IL-13-induced gob-
let cell metaplasia. We previously reported finding
that NFA inhibits the UTP-induced increase in chlo-
ride ion transport caused by IL-13-induced hCLCA1
expression in a human bronchial epithelial cell line.8
Although our findings suggested that hCLCA1 modu-
lates chloride ion transport, the role of hCLCA1 in the
goblet cell degranulation in the pathophysiology of
asthma remains unclear. mCLCA3 has been found to
be localized to mucus granule membranes by immu-
noelectron microscopy in mice,9 suggesting that
mCLCA3 is related to goblet cell secretion. In the
present study we investigated whether NFA affects
the secretory response of the mucus granules in gob-
let cells in an asthma model. We used the OA sensiti-
zation model of asthma in guinea pigs in vivo and the
culture model of goblet cell metaplasia induced by IL-
13 in vitro, because the guinea pig model is suitable
for assessing goblet cell degranulation in vivo,10,11
and because human IL-13 has the ability to induce
guinea pig tracheal epithelial cells to differentiate into
goblet cells in vitro.12
METHODS
OA CHALLENGE EXPERIMENT
All protocols were approved by the Animal Care and
Use Committee of Tokyo Women’s Medical Univer-
sity. Pathogen-free male Dunkin-Hartley guinea pigs
weighing between 250 and 300 g were sensitized by
intraperitoneal injection of OA (70 mgkg, Sigma
Chemical Co., St. Louis, MO, USA) on the Day 1 and
Day 8. On the Day 22, after anesthetizing the animals
with pentobarbital (50 mgkg) intraperitoneally, the
larynx and upper trachea were exposed, and the tra-
chea was incised just below the larynx, and an intuba-
tion tube was inserted 3 mm into the trachea, and the
guinea pigs were artificially ventilated (frequency, 70
breathsmin; tidal volume, 10 mlkg) with a constant-
volume ventilator (model SN-480-7, Shinano Co., To-
kyo, Japan). To investigate the effect of NFA on gob-
let cell degranulation in response to OA challenge,
aerosols were generated with an ultrasonic nebulizer
(Pulmo-Sonic model-25, De Vilbiss Co., Somerset,
PA, USA) at 0.2 mlmin and delivered via the tracheal
tube during mechanical ventilation. NFA (Sigma
Chemical Co.) was dissolved in 0.4 M NaHCO3 in 5%
glucose.7 NFA (30 mgkg) or vehicle solution was ad-
ministered by inhalation for 2 min, and 10 min later,
5% OA or saline was administered by inhalation for 2
min. Because NFA has the ability to inhibit cyclooxy-
genase, we evaluated the effect of indomethacin (1
mgkg) on OA-induced goblet cell degranulation by
the same protocol as used for NFA.
Although we did not use an adjuvant for sensitiza-
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Fig.　2　Transmission electron micrographs of tracheal epithelium after OA challenge. A) Trache-
al epithelium at low magnifi cation. a) Saline challenge, b) OA challenge, c) NFA-pretreated, OA 
challenge. G: goblet cells. F: intercellular fl uid. Scale bar = 10 μm. After OA challenge, goblet cell 
(G) volume reduced by degranulation, and intercellular fl uid (F) appeared (b). NFA inhibited these 
changes (c). B) Goblet cells at high magnifi cation. a) Saline challenge, b) OA challenge, c) NFA-
pretreated, OA challenge. Scale bar = 1 μm. OA challenge induced disappearance of mucus gran-
ules. NFA-pretreated, OA-challenged goblet cells contained a large number of fused granules 
without dense cores.
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tion in this model, in preliminary experiment we con-
firmed an increase in the serum guinea pig OA-
specific IgE level on Day 22 in all sensitized animals
by ELISA (Cusabio Biotech Co., Newark, DE, USA)
(OA-sensitized vs. non-sensitized animals, 0.116 ±
0.007 vs. 0.064 ± 0.005 OD; p < 0.0005, n = 7). The re-
sults showed that the OA-sensitized guinea pigs venti-
lated with the respirator exhibited acute respiratory
distress at ~1 min after OA challenge, but that the
non-sensitized guinea pigs did not, indicating that
sensitization with OA alone was sufficient to induce
an immediate asthmatic response in guinea pigs, the
same as reported by others.13
For the morphological assessment, the trachea was
removed and fixed for 24 h with 10% formal saline.
The tracheal sections were then cut longitudinally in
the coronal plane (5 μm thick) and stained with peri-
odic acid-Schiff (PAS) and alcian blue (AB) to demon-
Kondo M et al.
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Fig.　3　Effect of nifl umic acid (NFA) on goblet cell degranulation induced by histamine 
(Hist) challenge in OA-sensitized trachea. A) Photomicrographs of tracheal epithelium 
(PAS/alcian blue stain). a) Saline challenge, b) histamine challenge, c) NFA-pretreated, 
histamine challenge. Scale bar = 20 μm. B) Comparison of the PAS/alcian-blue-positive 
mucus area as a percentage of the total area of the tracheal epithelium measured with 
computer image analysis software. n = 4, **p < 0.01, histamine challenge vs. saline chal-
lenge or NFA-pretreated, histamine challenge.
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strate the acidic and neutral intracellular glycoprotein
in the goblet cells. A semiautomatic image analysis
system (Win Roof, Mitani Co., Fukui, Japan) was
used to measure the PASAB-positive area and the to-
tal tracheal epithelial area, and the mucus area
stained with PASAB was calculated as a percentage
of the total area of tracheal epithelium. For electron-
microscopic examination, the tissues were fixed with
glutaraldehydeosmium tetroxide and embedded in
epon. The sections (with a silver interference color)
were stained with lead citrate and uranyl acetate.
HISTAMINE CHALLENGE EXPERIMENT
Since in a previous study we reported that the hista-
mine level in airway tissue increased after an OA
challenge in the same guinea pig model of asthma
used in the present study,14 next we investigated the
effect of NFA on histamine-induced goblet cell de-
granulation in the OA-sensitized model. NFA or vehi-
cle solution was administered by inhalation for 2 min,
and 10 min later histamine (2 mgml) was adminis-
tered by inhalation during 30 breaths as previously
reported.14 The mucus area was measured as de-
scribed above.
UTP CHALLENGE EXPERIMENT
Since UTP directly stimulates the P2Y2 receptor in
airway epithelial cells and causes mucin secretion via
a Ca2+-dependent pathway,15-17 we used UTP as a se-
cretogogue to clarify the Ca2+-dependent action of
CLCA in goblet cells in this model. NFA or vehicle
solution was administered by inhalation for 2 min,
and 10 min later UTP (10-4 M) or saline was adminis-
tered by inhalation for 5 min. The mucus area was as-
sessed as described above.
In vitro UTP EXPERIMENT
IL-13-induced cultured goblet cells were used to clar-
ify the mechanism of the direct effect of NFA on UTP-
induced goblet cell degranulation in vitro. Tracheal
epithelial cells from Dunkin-Hartley guinea pigs were
isolated by digestion with 0.05% protease (type XIV,
Sigma Chemical Co.) at 4℃ overnight, and after pel-
leting (200 g, 10 min) the cells and suspending them
in a 50 : 50 mixture of Dulbecco’s modified Eagle me-
dium (DMEM) and Ham’s F12 medium (GIBCO,
Grand Island, NY, USA) containing 5% fetal calf se-
rum, they were plated at 2.5 × 105 cells per cm2 onto
polycarbonate inserts having a diameter of 12 mm,
pore size of 0.4-μm, and thickness of 10-μm (Costar
Transwell, Cambridge, MA, USA) and that had been
coated with human placental collagen (type XVI,
Sigma Chemical Co.). After 24 hours, the cells were
cultured with serum-free, hormonally defined me-
Niflumic Acid Inhibits Mucus Secretion
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Fig.　4　Effect of nifl umic acid (NFA) on goblet cell degranulation induced by UTP chal-
lenge in OA-sensitized trachea. A) Photomicrographs of tracheal epithelium (PAS/alcian 
blue stain). a) Saline challenge, b) UTP challenge, c) NFA-pretreated, UTP challenge. 
Scale bar = 20 μm. B) Comparison of the PAS/alcian-blue-positive mucus area as a per-
centage of the total area of the tracheal epithelium measured with computer image analy-
sis software. n = 4, **p < 0.01, UTP challenge vs. saline challenge or NFA-pretreated, 
UTP challenge.
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dium as previously reported,12 and when they had
reached confluence, the apical medium was removed,
and the cells were fed from the basolateral side alone
with 1 ml of medium containing human recombinant
IL-13 (10 ngml, Biosource International, Camarillo,
CA, USA). The cells were cultured at the air-liquid in-
terface for 14 days with medium containing IL-13. On
day 14 a large number of mature goblet cells were
present as reported previously.12
The cells were washed with Hank’s balanced salt
solution (HBSS) containing10 mM N-2-hydroxyethyl-
piperazine-N’-2-ethane sulfornic acid (HEPES) (pH
7.4). A 0.2 ml volume of HBSS was added to the Tran-
swell on the apical side and 1.0 ml of HBSS added on
the basolateral side. The cells were preincubated in
the presence or absence of NFA (10-4 M, apical side
and basolateral side) for 20 min at 37℃, and then
stimulated with UTP (10-4 M, apical side and baso-
lateral side) for 20 min at 37℃. The cell lysate was
used for MUC5AC protein analysis. Some cell sheets
on the filters were used for morphological examina-
tion as previously reported.12
MUC5AC protein was measured by using ELISA as
reported previously.12 The cell lysate was prepared
with phosphate buffered saline (PBS) at multiple dilu-
tions, and 50 μl of each sample was incubated with
bicarbonate-carbonate buffer (50 μl) at 40℃ in a 96-
well plate (Nunc) until dry. The plates were washed
three times with PBS and then incubated with 50 μl of
mouse monoclonal MUC5AC antibody (clone 45 M1,
1 : 100, New Markers, Fremont, CA, USA), which
was diluted with PBS containing 0.05% Tween 20
(Sigma Chemical Co.). After 1 h, the wells were
washed three times with PBS, and 100 μl of horserad-
ish peroxidase-goat anti-mouse IgG conjugate (1 :
10,000, Sigma Chemical Co.) was added. After 1 h,
the plates were washed three times with PBS, color
was developed with 3,3’, 5,5’-tetramethylbenzidine
(TMB) peroxidase solution (Kirkegaard & Perry
Laboratories, Gaithersburg, MD, USA) and stopped
with 1 M H2SO4. Absorbance was read at 450 nm.
STATISTICS
All data are expressed as means ± SEM. Student’s un-
paired t-test was used for comparisons between two
groups. One-way ANOVA was used for comparisons
among three groups. Scheffe’s F test was used to cor-
rect for multiple comparisons when statistical signifi-
cance was identified by the ANOVA. A probability of
<0.05 for the null hypothesis was accepted as indicat-
Kondo M et al.
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Fig.　5　Transmission electron micrographs of tracheal epithelium after UTP challenge. A) Tra-
cheal epithelium at low magnifi cation. a) Saline challenge, b) UTP challenge, c) NFA-pretreated, 
UTP challenge. Scale bar = 5 μm. B) Goblet cells at high magnifi cation. a) Saline challenge, b) 
UTP challenge, c) NFA-pretreated, UTP challenge. Scale bar = 1 μm. Some of UTP-challenged 
goblet cells contained swollen granules containing a large dark area. In contrast, NFA-pretreated 
goblet cells contained the fused mucus granules containing a small dense core.
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ing a statistically significant difference.
RESULTS
OA CHALLENGE EXPERIMENT
As shown in Figure 1A, OA challenge induced goblet
cell degranulation in the OA-sensitized animals, and
NFA inhibited the degranulation response. The area
of PASAB-stained mucus in the tracheal epithelium
calculated by computer image analysis was smaller in
the OA-challenged animals than in the saline-
challenged animals (OA 6.3 ± 1.5% vs. saline 28.1 ±
4.2%, n = 4-6, p < 0.01, Fig. 1B). Pretreatment with
NFA inhibited the decrease in mucus area after OA-
challenge (OA 6.3 ± 1.5% vs. NFA+OA 28.0 ± 0.7%, n =
4-6, p < 0.01, Fig. 1B). By contrast, pretreatment with
indomethacin did not prevent the decrease in mucus
area after OA challenge (6.4 ± 1.8%, n = 4, Fig. 1B).
TEM photographs of goblet cells after OA-challenge
are shown in Figure 2. The goblet cells in the saline-
challenged animals contained numerous mucus gran-
ules containing a dense core (Fig. 2Aa, Ba), whereas
the goblet cells in the OA-challenged animals were
Niflumic Acid Inhibits Mucus Secretion
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Fig.　6　Effect of NFA on UTP-induced mucus secretion by cultured tracheal 
epithelial cells. A) Photomicrographs of cultured tracheal epithelial cells (Tolu-
idine blue stain). a) UTP-stimulated epithelial cells, b) NFA-pretreated, UTP-
stimulated epithelial cells. Scale bar = 10 μm. UTP-stimulated cells contained 
numerous vacuoles, whereas NFA-pretreated, UTP-stimulated cells had few 
vacuoles. B) MUC5AC level in the cell lysate after UTP stimulation. n = 4. *p < 
0.05, UTP-stimulated cells vs. NFA-pretreated, UTP-stimulated cells. Data are 
shown as a percentage of the level in the non-stimulated control cells.
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smaller and contained only a small number of mucus
granules. Thus, OA challenge had induced strong de-
granulation (Fig. 2Ab, Bb). In addition, intercellular
fluid collection was observed in the OA-challenged
epithelium. By contrast, after the OA challenge the
NFA-pretreated goblet cells did not exhibit any
change in cell size and contained a large number of
mucus granules with or without a dense core (Fig. 2
Ac, Bc).
HISTAMINE CHALLENGE EXPERIMENT
Histamine (2 mgml, 30 breaths) induced robust gob-
let cell degranulation and an increase in the intracel-
lular space of epithelium in the OA-sensitized guinea
pigs (Fig. 3A). The area of PASAB-stained mucus in
the histamine-challenged animals was smaller, and
pretreatment with NFA significantly inhibited the
histamine-induced decrease in mucus area (hista-
mine 2.8 ± 0.6% vs. NFA+histamine 16.0 ± 1.2%, n = 4,
p < 0.01, Fig. 3B).
UTP CHALLENGE EXPERIMENT
The area of PASAB-stained mucus in the UTP-
challenged animals was smaller, and pretreatment
with NFA significantly inhibited the decrease in mu-
cus area induced by UTP (UTP 13.0 ± 1.5% vs. NFA+
UTP 26.5 ± 1.0%, n = 4, p < 0.01, Fig. 4). TEM photo-
graphs of goblet cells after UTP-challenge are shown
in Figure 5. Some of the goblet cells in the UTP-
challenged epithelium contained swollen mucus
granules that contained a large dense core (Fig. 5Ab,
Bb), whereas the NFA-pretreated UTP-challenged
goblet cells contained mucus granules that had a
small dense core (Fig. 5Ac, Bc), the same as the
saline-challenged goblet cells (Fig. 5Aa, Ba).
In vitro UTP EXPERIMENT
The tracheal epithelial cells cultured in the presence
of IL-13 for 14 days contained a large number of ma-
ture goblet cells. After UTP stimulation, the number
of mucus granules decreased, and light microscopy
revealed many vacuoles in the goblet cells (Fig. 6Aa).
NFA inhibited these changes (Fig. 6Ab). The
MUC5AC level in the cell lysates was lower after UTP
stimulation for 20 min, indicating that UTP induced a
secretory response. NFA significantly inhibited the
UTP-induced decrease in MUC5AC level (Fig. 6B).
The TEM photographs of the UTP-stimulated gob-
let cells showed swelling of the granules, exocytosis,
and vacuole formation (Fig. 7a, b), whereas the mu-
cus granules in the NFA-pretreated UTP-stimulated
cells were not swollen (Fig. 7c).
DISCUSSION
The results of this study demonstrated that NFA in-
hibits antigen-, histamine- and UTP-stimulated goblet
cell degranulation in a guinea pig asthma model, and
the transmission electron microscopy findings dem-
onstrated that NFA inhibits the morphological
changes in mucus granules.
Since antigen sensitization induces CLCA expres-
sion, we speculated that NFA might have inhibited
the goblet cell degranulation induced by OA chal-
lenge via a CLCA-dependent pathway. The TEM pho-
tographs (Fig. 2) of OA-challenged goblet cells show-
ed loss of mucus granules and a decrease in cell size,
Kondo M et al.
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Fig.　7　Transmission electron micrographs of mucus granules in cultured goblet cells. a) , 
b) UTP-stimulated goblet cells, c) NFA-pretreated, UTP-stimulated goblet cells. Scale bar 
= 1 μm. UTP-stimulated goblet cells contained swollen of granules and exhibited vacuole 
formation (a) and exocytosis (b). NFA-treated, UTP-stimulated goblet cells contained no 
swollen granules (c).
suggesting that strong degranulation had occurred,
whereas NFA-pretreated, OA-challenged goblet cells
retained a large number of mucus granules. Interest-
ingly, the TEM photographs showed that some gran-
ules did not have a dense core. These findings sug-
gested that NFA inhibits the secretory response by
affecting mucus granules directly.
Antigen challenge causes the mast cells of sensi-
tized animals to release chemical mediators such as
histamine and cysteinyl-leukotrienes. These media-
tors are reported to induce goblet cell degranulation
in guinea pigs.11,18,19 We previously reported that the
histamine level of airway tissue increased after OA
challenge in the same guinea pig asthma model.14 In
the present study NFA inhibited histamine-induced
goblet cell degranulation (Fig. 3), suggesting that
NFA inhibits OA-challenge-induced goblet cell de-
granulation via a histamine-dependent pathway. How-
ever, it is still unclear whether agonists such as hista-
mine or acethylcholine directly activate receptors on
airway goblet cells or induce airway smooth-muscle
contraction leading to ATP.20 UTP as well as ATP is a
well-known mediator that directly stimulates mucin
secretion activated via P2Y2 receptors followed by in-
tracellular Ca2+ elevation in airway goblet cells,15-17
and UTP could be used as a secretagogue with less
effect on bronchospasm than hypertonic saline in
asthma patients.21 Therefore, we next investigated
the effect of NFA on UTP-induced goblet cell de-
granulation in OA-sensitized trachea to more clearly
identify the role of CLCA in Ca2+-dependent secretory
response.
As shown in Figure 4, Figure 5, NFA inhibited
UTP-induced goblet cell degranulation. The TEM
photographs showed swollen mucus granules con-
taining a large dense core in UTP-stimulated goblet
cells, and that NFA inhibited these morphological
changes. The results of the in vitro experiment
showed that NFA had a direct inhibitory effect on the
secretory response of IL-13-induced goblet cells. As
shown in Figure 6A, Figure 7, UTP induced swelling
of mucus granules containing a large dense core, exo-
cytosis, and vacuole formation in the cultured goblet
cells, whereas NFA inhibited these changes. Since it
has been reported that IL-13 induces hCLCA1 and
mCLCA3 expression in human and murine goblet
cells in vitro and that mCLCA3 is located in murine
mucus granule membranes, the inhibitory effect of
NFA on goblet cell degranulation might be associated
with blockade of granule-located CLCA. Bertrand CA
et al. showed that NFA inhibits ATP-stimulated exo-
cytosis in colon cancer epithelial cell line, HT29-
Cl.6E, which differentiates into a goblet-cell-like epi-
thelium containing a large number of mucin granules
in their apical cytoplasm.22 Gibson A et al. reported
that hCLCA1 and mCLCA3 are secreted, non-integral
membrane proteins, not ion channels, and that they
detected N-terminal cleavage products of hCLCA1
Niflumic Acid Inhibits Mucus Secretion
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and mCLCA3 in bronchoalveolar lavage fluid from
asthma patients and OA-challenged mice.23 Hamann
M et al. demonstrated that hCLCA1 is not an ion
channel per se but a modulator of anionic conduction
of Ca2+-dependent chloride currents.24 NFA is a non-
steroidal anti-inflammatory agent that was originally
determined to be a potent, reversible blocker of endo-
genous calcium-activated Cl- currents in Xenopus oo-
cytes.25 Our findings suggest that the CLCA may be
involved in goblet cell degranulation, but it is still un-
certain whether the action of NFA is dependent on
blockade of Ca2+-dependent Cl- currents. Further-
more, because NFA has the ability to inhibit cy-
clooxygenase, the inhibition of mucus secretion by
NFA may be mediated by a cyclooxygenase-
dependent pathway.26 However, that seems unlikely
because indomethacin did not inhibit OA-induced
goblet cell degranulation in the present study as re-
ported by others in sensitized rats27 (Fig. 1B).
Goblet cell degranulation, mucus production, and
goblet cell metaplasia are different phenomena, and
whether they are linked remains unknown. hCLCA1
is known to be associated with goblet cell metaplasia,
and our findings suggested that CLCA, presumably
type hCLCA1, may be associated with goblet cell de-
granulation. If that is true, CLCA may play an impor-
tant role in both the rapid secretory response and de-
layed remodeling process of goblet cells. Unfortu-
nately, no counterpart of hCLCA1 has yet been identi-
fied in guinea pigs, but the counterparts of hCLCA1
in mice, pigs, and horses have been reported to be
mCLCA3, pCLCA1, and eCLCA1, respectively, all of
which belong to CLCA cluster 1 in the phylogenic
tree,28 suggesting that CLCAs, including hCLCA1,
are ubiquitous molecules in animals.
Mucus hypsersecretion causes airway narrowing,
loss of lung function, and, occasionally, asphyxia, in
asthma. However, no specific treatment for mucus
hypersecretion exists. Since hCLCA1 has been re-
ported to be associated with hypersecretion not only
in asthma, but in COPD and cystic fibrosis,29,30 CLCA
inhibitors may be useful for the treatment of mucus
hypsersecretion in various airway diseases.
In conclusion, NFA was found to inhibit goblet cell
degranulation induced by OA-challenge, histamine,
and UTP in in vivo and in vitro asthma models, sug-
gesting that CLCA may regulate secretory responses
and that inhibitors may be useful in treating the hy-
persecretion in asthma patients.
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